Jamie Christensen - May 24, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP & Chief Scientific Officer
Signature
/s/ Laurie Stelzer, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
May 24, 2023
Transactions value $
-$28,035
Form type
4
Date filed
5/24/2023, 07:38 PM
Previous filing
Jan 24, 2023
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$28K -619 -0.5% $45.29 124K May 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on May 21, 2020.